CYREN (CYRN) Tops Q3 EPS by 1c

CYREN (NASDAQ: CYRN) reported Q3 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $7.9 million versus the consensus estimate of $7.9 million.

For earnings history and earnings-related data on CYREN (CYRN) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Greenlane Holdings Inc. (GNLN) reported Q2 result
• Vivos Therapeutics (VVOS) Tops Q2 EPS by 6c